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Recently, it has been demonstrated that the skin-infiltrating 
T cells express cutaneous lymphocyte-associated antigen, 
which is the ligand of E-selectin or endothelial-leukocyte 
adh esion molecule, suggesting that cutaneous lymphocyte-
associated antigen functions as the homing receptor of the 
skin infiltrating T cells. In contrast, the m echanism for the 
m igration of Langerhans cell s from the bone marrow to the 
skin has not been clarified. Sialyl Lewisx acts as a ligand for 
endothelial-leukocyte adhesion molecule and granule mem-
brane protein 140. We examined the expression of sialyl 
Lewisx in epidermal dendritic cells in human skin. Two-co-
lor immunofluorescence study on an epidermal sheet re-
vealed that human leukocyte antigen DR+ or CDla+ epider-
mal dendritic cel ls were partially sialyl Lewisx+, although all 
of the sialyl Lewisx+ dendritic ce lls were human leukocyte 
C ell surface carbohydrates were reported to playa role in cellular interactions during cell differentiation and maturation process [1,2] . Stage-specific embryonic antigen-1 (SSEA-l) (LeX-i) , one of cell surface carbo-hydrates, was also at first shown as a stage-specific 
embryonic antigen by Solter and Knowles [1] , but it has been found 
to be significantly expressed in human colon cancer [3] . Because the 
expression of the sialylated form of the SSEA-1 antigen (sialyl 
LeX-i) was noted on various other tumors, the latter was suggested 
to be one of tumor-associated antigens [4 - 8]. However, its presence 
has recently been reported on granu locytes, natural killer cells, and 
immature lymphocytes of T and B cell lymphocytes [9]. Recent 
studies have indicated that sialyl LeX (SLeX) is a li gand for endothe-
lial -leukocyte ad hesion molecules (ELAM-l) [10,11] and granule 
membrane protein 140 (GMP-140) [1 2, 13]. These findin gs indicate 
a critical rol e played by SLex in the interaction between circulating 
leukocytes and endothelial cel ls. 
W eare interested in detecting a ligand for the migration of Lan-
gerhans cells (Le) , which originate from the bone marrow to the 
skin. The expression of carbohydrate antigens on the epidermal 
cells has been investigated by several authors [1 4 - 16] and Dabel-
steen el al have reported the presence of SLex+ dendritic cells in the 
normal epidermis [17] . However, from their data it is not clear 
whether these SLex+ dendritic cells are LCs and, if so, whether or 
not all of the epidermal LCs express SLex or on ly some population 
of LCs express this antigen. 
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antigen DR+ and CDla+. Further analysis of these dendritic 
cells by flow cytometry demonstrated that most of the 
human leukocyte antigen DR+ and CDla+ epidermal cells 
expressed sia lyl Lewisx, although the m agnitude of its ex-
pression was more variable than that of CD 1a expression, and 
that some of human leukocyte antigen DR + cells were clearly 
sialyl Lewisx-. Immunoperoxidase study of normal skin 
showed the presence of sialyl Lewisx+ dendritic cells not only 
in the epidermis but also in the upper dermis. These data 
demonstrating the heterogeneity of the expression of sialyl 
LewisX by epidermal Langerhans cells sugges t their possible 
relationship to the stage of maturation as well as to the mi-
gration of Langerhans cells from the bone marrow to the 
skin. Key words: adhesion molecule/ELAM-l / flow cytom-
etry.] 111l1est DermatoI101 :175-179, 1993 
In this study, we have performed immunofluorescent staining for 
epidermal sheet preparations, and flow cytometry for epidermal cell 
suspensions as well as immunoperoxidase staining for skin cryostat 
sections. W e have found weak to strong expression ofSLex by most 
of the human leukocyte antigen {HLA)-DR+ epidermal LCs and its 
expression by some dermal cells. 
MATERIALS AND METHODS 
Antibodies The antibodies we used were the following: FH6 specific for 
SLex (a gift from Dr. Y. Fukushi , Department of Urology, T ohoku Univer-
sity School of Medicine, Sendai,J apan), purified or biotinylated anti - HLA-
DR antibody (Becton Dickinson, Mountain View, C Al, purified or fluores-
cein isothiocyanate (FITC) -conjugated OKT6 (anti-COl a antibody) 
(Ortho Diagnostics Systems, Raritan, NJ), FITC-conjugated goat F(ab'), 
fraction of anti-mouse immunoglobulin (IgG) (1' and light chains), biotiny-
lated goat anti-mouse IgG and IgM, Texas red-conjugated goat F(ab'), frac-
tion of an ti-mouse IgG and IgM, Texas red-co,~ugated avidin, phycoer-
ythrin (PE) -conjugated av idin (TAGO, Burlingame, CAl. Relevant 
isotypc-matched mouse monoclonal antibodies from mouse immunoglobu-
lin standards (PharMingen, San Diego, CAl were used as negative controls. 
Epidermal Sheets Epidermal shee ts were prepared from unaffected skin 
of two adu lt viti ligo patients and from normal skin from three healthy 
volunteers with the suction blister (epidermal grafting) method as described 
previously (1 8]. Al l subjects gave informed consent before the examination. 
The epidermal sheets from viti ligo patients were obtained from a part of 
uninvolved epidermal sheets during epidermal grafting. Briefly, we raised 
blisters, approximately 2 cm in diameter, applying a negative pressure of200 
to 400 mm H g from 20-ml disposable plastic syringes placed on the skin of 
the abdomen for 1 to 2 h. Part of the blister top was washed in phosphate-
buffered sal ine (PBS), fi xed in acetone at room temperature for 20 min, and 
stored in 1 % bovine serum albumin in PBS . 
Immunofluorescence Staining of Epidermal Sheet and Enumera-
tion of SLex+ Langerhans Cells Epidermal sheets prepared by the suc-
tion blister method from the five subjects were incubated with the above-
mentioned different primary antibodies for 3 h at room temperature, washed 
three times with PBS, and then incubated with FITC-conjugated goa t anti-
mouse IgG for 1 h at room temperature. After washing three times with 
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Figure 1. Two-color immunofluorescence staining of epidermal sheets 
from normal human skin. Specimens were stained with FH6 (FITC)/anti -
HLA-DR (Texas red) (a and b), FH6 (FITC)/isotype-matched control 
(Texas red) (. and d) , isotype-matched control (FITC)/anti - HLA-DR 
(Texas red) (e and j), isotype-matched control (FITC)/isotype-matched 
control (Texas red) (g and h). Bar, 150 /lm . 
PBS, the specimens were mounted with PermaFluor (Lipshaw Immunon, 
Pittsburgh, PAl. For two-color immunofluorescence staining, the following 
combinations of immunofluorescence sta ining were performed: 1) purified 
monoclonal antibody (FH6 or isotype-matched control IgM antibody) fol-
lowed by the incubation with FITC-conjugated goat anti-mouse IgG and 
biotinylated monoclonal antibody (biotinylated anti - HLA-DR antibody or 
biotinylated isotype-matched control) followed by reaction w ith Texas red -
conjugated avidin; 2) purified monoclonal antibody (FH6 or isotype-
matched contro l) followed by the incubation with Texas red- conjuga ted 
anti-mouse IgG and FITC-conjugatcd monoclonal antibody (FITC-COlljU-
gated anti-CDla or FITC-conju~ated isotype-matched control); and 3) 
F1TC-conjugated monoclonal antibody (FITC-conJugated antl-CD l a or 
FITC-conjugated isotype-matched control) and biotinylated monoclonal 
antibody (biotinylated anti - HLA-DR antibody or biotinylated isotype-
matched control) followed by reaction with Texas red-conjugated av idin. 
The specimens were incubated in normal mouse serum for 30 min between 
each immunofluorescence staining. Finally, we took pictures of three ran-
domly selected different fields at SOX for each two-color immunofluo-
rescence staining and counted more than 50 cells for each fi eld. The data 
were expressed as the mean ± SD of percent of SLcX+ cells among HLA-
DR+ or CD l a+ dendritic epidermal ce ll s. 
Langerhans Cells-Enriched Epidermal Cell Suspensions A frag-
ment of fresh normal human skin was obtained from an edge of a sp lit-thick-
ness skin graft taken from the normal buttock skin of two patients who had 
undergone skin surgery. An epidermal sheet was separated by treating it with 
0.5% trypsin in PBS at 4"C overnight, and epidermal cell suspcllsions were_ 
obtained after treatment with DNase [19] . They were applied on Ficol-
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Figure 2. Two-color immunofluorescence staining of epidermal sheets 
from normal human skin . Specimens were stained with anti-CDl a (F1TC)/ 
FH6 (Texas red) (a and b), FH6 (FITC)/anti- HLA-DR (Texas red) (c and 
d), anti-CDla (FITC)/anti - HLA-DR (Texas red) (e and]). Bar, 150/lm. 
paque density gradient and the interface cells were used as LC-enriched 
epidermal cell suspensions. 
Two-Color Flow Cytometry Analysis of Langer hans Cells The LC-
enriched epidermal cell suspension was first incubated with FH6, anti-
C Dla, or appropriate isotype-matched control monoclonal antibodies on ice 
for 30 min , washed three times with PBS supplemented with 1 % FCS and 
0.02% NaN), and fo llowed by FITC-conjugated goat anti-mouse IgG and 
IgM . After washing three times with PBS, aliquots were incubated in normal 
mouse serum and then labeled with biotin-conjuga ted anti - HLA-OR anti-
body, followed by phycoerythrin-conju gated av idin. Immullolabeling was 
performed at 4 °C. Fluorescence profiles were generated using a fluores-
cence-activated cell so rter scan and Consort 30 softwa re (Becton Dickin-
son). 
Immunoperoxidase Staining of the Skin Normal human skjn was 
obtained from the surrounding portion of pigmented nevus in two healthy 
subjects embedded in O CT compound (Miles, Elkhart, IN) and snap frozen 
in acetone with dry ice. Six-micron cryostat sections preparcd from it were 
fixed in cold acetone for 10 min, washed in PBS, and stained with an 
avidin-biotin peroxidase method [20] . Briefly, after blocking with 1% horse 
serum diluted in PBS, sections were serially treated with 1 Jlg/ml of FH6, 
anti-CD l a, anti - HLA-DR antibodies or isotype-matched control mouse 
monoclonal antibodies at 4"C overnight, thereafter with biotinylated anti-
mouse IgG for 30 min, and with peroxidase conjugated avidin for 30 min. 
Each step was followed by was hing three times with PBS. The reagents for 
avidin-biotin peroxidase technique (Histofine SAB-PO(M) kit) was pur-
Table I. Percentage of SLeX + Cell in Epidermal HLA-DR+ 
Cells or CDla+ Cells 
Case 
1 
2 
3 
4 
5 
'Mean ± SO. 
SLex+ Cells/DR+ Cell s 
77 ± 17' 
40 ± 28 
ND' 
ND' 
64 ± 10 
b ND, Not done 
SLex+ Cells/CDla+ Cells 
73 ± 18 
74± 5 
89 ± 6 
74 ± 3 
ND' 
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Figure 3. Two-color immunofluorescence analysis of freshly prepared epidermal cell suspension by fluorescence-activated cell sorter. Epidermal ce ll 
suspensions were stained with FH6 (x) and anti-HLA-OR (y) (A), isotype-matched control (x) and anti - HLA-OR (y) (B), FH6 (x) and isotype-matched 
control (y) (C) , isotype-matched control (x) and (y) (D), anti-COla (x) and anti - HLA-OR (y) (E), isotype-matched control (x) and anti-HLA-OR (y) (F) , 
anti-COla (x) and isotype-matched control (y) (G) , and isotype-matched control (x) and (y) (H). 
chased from Nichirei, Tokyo, J apan. Finally, the sections were developed 
with diaminobenzidine solution and 1 % hydrogen peroxide, and counter-
stained with Mayer's hematoxylin. 
RESULTS 
SLex+ Cells in Epidermal Sheets The results of two-color im-
munofluorescent staining using various combinations of anti -
HLA-DR, anti-CD l a, and FH6 antibodies performed in epidermal 
sheets were shown in Figs 1 and 2. All th e HLA-DR+ cells or 
CD la+ cells were not necessarily SLex+, whereas all the SLex+ cells 
were HLA-DR+ and CD l a+. Actual percentages ofSLex- reactive 
cell s among HLA-DR+ cells or CDla+ cells were shown in Table I. 
The percentages of SLex+ ce lls among HLA-DR+ cells and in 
CDl a+ cells varied from 40% to 77% and from 73% to 89%, re-
spectively. 
Flow Cytometry of LC Stained with Two-Color Immuno-
fluorescence Two-color immunofluorescent staining using 
various combinations of anti- HLA-DR, anti-CD l a, and FH6 was 
fur ther examined in the epidermal cell suspensions with flow cy-
tom etry. The data presented in Fig 3, which are representative data 
of three different experiments, showed that most of the HLA-DR+ 
epidermal celis, which were also CD1a+, expressed SLex. The level 
of SLex expression by HLA-DR+ cells was more variable than that 
of CD 1a (Fig 4). Furthermore, some of the HLA-DR+ ceJls were 
SLex-. 
SLex+ Cells in the Skin Immunoperoxidase staining of the skin 
using FH6 revealed t11e presence of FH6-reactive (SLex+) cells not 
only in the epidermis but also in the upper dermis (Fig Sa). Some 
kera tinocytes also showed weak positive staining. The number of 
SLex+ epidermal dendritic cells was fewer than that of HLA-DR+ 
cells or CD1a+ cel ls (Fig Sa,b,e). In the dermis, the number ofSLex+ 
cells was far less than that ofHLA-DR+ but almost similar to that of 
CDla+ cells (Fig Sa,b,e). 
DISCUSSION 
Recently, Picker et al [21,22) reported that the skin-infiltrating T 
cells express cutaneous lymphocyte-associated antigen (CLA) rec-
ognized by monoclonal antibody HECA-4S2, and that this anti gen 
turns out to be the ligand of ELAM-1, suggesting that CLA func-
CD1a 
CiJ A 8 
.D 
E 
=> 
z 
Q) 
0 
OJ 
> 
~ 
OJ 
a: 
lill! 19 2 leI! 11i3 
Fluorescence Intensity 
Figure 4. Histogram of FH6+ ce lls or C01a+ cells among HLA-OR+ epi-
dermal cell s. These histograms were obtained from the same samples used in 
Fig 3. A, SLex+ ce lls stai ned with FH6. B, C01a+ cell s. 
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Figure 5. Expression ofSLex, COla, and HLA-OR in normal skin. Cryostat skin sections were stained with each antibody for FHG (a) , HLA-OR (b), COla 
(c), and with isotype-matched control (d). Bar, 100/.lm. 
tions as a homing receptor of the skin-infiltrating T cells. Further-
more, it has been demonstrated that ELAM-l is expressed on the 
vascu lar endothelial cells even in the normal skin, although the 
expression is weak or moderate [23J. These observations indicate 
that the interaction with ELAM-l may playa crucial role in con-
trolling the homing phenomenon of other leukocytes into the skin. 
Langerhans cells originate from the bone marrow [24J . However, 
the mechanisms underlying the migration ofLCs or th e precursors 
of LCs from bone marrow to the skin have not been clarified 
yet. . 
Sialyl Lewisx, whose expressIOn was first reported in various 
tumors, has recently been demonstrated to be present on granu lo-
cytes, natural killer cells, and immature lymphocytes ofT-cell and 
B-cel ilineages [9J. Furthermore, it has been found that SLeX func-
tions as a ligand for vascular selectin families, ELAM-l [10,11] and 
GMP- l40 [12,13 J. These observations suggest a role of SLex on 
leukocytes for their ad hesion on vascular endothelial cells. 
In this study, we have demonstrated the expression of SLeX on 
most of the CDl a+ and HLA-DR+ epidermal dendritic cells in the 
skin. Furthermore, subsequent flow cytometry also demonstrated 
that most of HLA-DR+ and CD1a+ epidermal dendritic cells ex-
pressed SLex, although the magnitude of their SLex expression was 
more va riable than that of their CDla expression. These data sug-
gest a possible mechanism by which LCs or their precursors migrate 
into the skin through the cutaneous vessels via the interaction be-
tween SLex and ELAM-l. Indeed, our subsequent immunoperoxi-
dase sta ining of normal skin with FH6 showed the presence of the 
SLex+ cells not only in the epidermis but also in the upper dermis. 
Our data by two-color immunofluorescence study using epider-
mal sheets showed that some of HLA-DR+ and CDla+ epidermal 
dendritic cells are SLex-. It is also demonstrated by flow cytometry' 
that some ofHLA-DR+ cells are SLex-, whereas all the HLA-DR+ 
cells are CD1a+. These data indicated that some of LC are SLex-. 
Sialyl Lewisx has been reported to be expressed on immature lym-
phocytes ofT- and B-ceillineages but to disappear during the pro-
cess of maturation [9J; its expression on LCs also might be related to 
the stage of maturation. It is well-known that LCs take two differ-
ent phenotypic and functional characteristics [25 - 28J: namely, 
freshly isolated LCs express weak class II antigen, show weak or 
minimal allogeneic and syngeneic T-cell stimulatory function and 
potent antigen processing capacity, whereas cultured LCs express 
more class n, major histocompatibility complex antigen show vig-
orous allogeneic and syngeneic T-cell stimulatory function and de-
creased antigen processing capacity . We have recently reported that 
even in vivo, epidermal LCs can take these phenotypic and func-
tional characteristics similar to cultured LCs [25J . Thus, SLex ex-
pression on LC may be related to such different functiona l charac-
teristics of LC. 
Several authors have reported that keratinocytes also express SLex 
[17,29J. Indeed, our immunohistologic staining of cryostat sections 
sometimes revealed epidermal membrane staining of SLeX, al-
though the magnitude of SLex expression by keratinocytes was 
much weaker than that by LC (data not shown) . Symington et al [29J 
recently reported that the basal surface of an intact epidermal sheet 
was stained with anti-SLex antibody. From their paper, it is not clear 
how they prepared those specimens. By using the same anti-SLex 
antibody , however, our immunohistologic staining could not 
clearly reveal SLex expression by keratinocytes, whereas dendritic 
cells were brightly stained. Even in our fl ow cytometry study, we 
could not demonstrate the expression of SLeX by keratinocytes, 
which should be HLA-DR - SLex+. However, we cannot rule out 
the possibility that the Ficol-paque density gradient of epidermal 
cell suspensions performed to enrich epidermal dendritic cells 
might lose SLeX + keratinocytes. 
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ANNOUNCEMENT 
Cutaneous Malignancies: 1994 Skin Cancer Update will be held Friday to Sunday, January 
21-23, 1994, sponsored by Scripps Clinic and Research Fou ndation, at the Sheraton Grande 
Torrey Pines Hotel, La Jolla, California. 
This course is designed for dermatologists, oculoplastic surgeons and ophthal mologists, head 
and neck surgeons, plastic surgeons, fami ly practice physicians , and other physicians with an 
interest in skin cancers. This course w ill provide an update on cutaneous neoplasms, melanoma, 
and facial reconstruction. The combination oflectures and optional hands on cadaver laboratory 
sessions wi ll expose the attendee to the latest information and tech niques. The course will offer 
17 hours of category I CME credit. 
For further information contact Department of Academic Affairs , 403C, Scripps Cli nic and 
Research Foundation, 10666 N . Torrey Pines Road, La Jolla, CA 92037. Telephone: (619) 
554-8556; FAX: (619) 554-6310. 
